About the Insulin Pumps Market
Diabetes is a common metabolic disease in which an individual's blood sugar level is high for a prolonged period. This is caused either because the pancreas stops secreting insulin or the body does not respond appropriately to insulin. The two types of diabetes include type 1 and type 2. In type 1 diabetes, the body does not produce sufficient insulin, and it is usually diagnosed in children and young adults. The most common type of diseases is type 2. In this type, the body is incapable of utilizing insulin.
Insulin pump therapy is the most preferred alternative delivery method of administrating insulin instead of insulin pens and needles. It is able to reduce the rate of recurrence of severe hypoglycemia and is capable of improving the quality of life for insulin pump users.
An insulin pump is a small-sized high-tech electronic device that can be connected to the body via an infusion set to deliver small doses of rapid-acting insulin to meet the basal needs. This device offers flexibility to people with type 1 diabetes.
Technavio’s analysts forecast the global insulin pumps market to grow at a CAGR of 8.05% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global insulin pumps market for 2016-2020. To calculate the market size, we consider revenue generated from the sale of insulin pumps.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Insulin Pumps Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the operating in this market.
Key vendors
• Animas
• Insulet
• Medtronic
• Roche Diagnostics
Other prominent vendors
• Bayer
• GlySens
• IA Collaborative
• MicroPort
• Senseonics
Tandem
• Valeritas
Market driver
• Focus on diabetes management
• For a full, detailed list, view our report
Market challenge
• Inadequate reimbursements
• For a full, detailed list, view our report
Market trend
• Adoption of insulin pumps over conventional methods
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
• Research methodology
PART 03: Market research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Background
PART 05: Insulin pumps: An overview
• Complications of diabetes
• Incidence and prevalence
• Insulin pump therapy
PART 06: Cost analysis
PART 07: Market landscape
• Market overview
• Market size and forecast
PART 08: Five forces analysis
PART 09: Leading country: Insulin pumps market in the US
• Market size and forecast
PART 10: Market segmentation by product type
PART 11: Geographical segmentation
• Insulin pumps market in Americas
• Insulin pumps market in EMEA
• Insulin pumps market in APAC
PART 12: Market drivers
• Increased prevalence of diabetes
• Increase in older adult population
• Focus on diabetes management
• Rise in public awareness
PART 13: Impact of drivers
• High cost
PART 14: Market challenges
• Availability of alternatives
• Inadequate reimbursements
• Intense competition among vendors
PART 15: Impact of drivers and challenges
PART 16: Market trends
• Advances in insulin pumps
• Adoption of insulin pumps over conventional methods
• Competitive scenario
PART 17: Vendor landscape
• Market share analysis 2015
• Animas
•
PART 18: Key vendor profiles
• Insulet
• Medtronic
• Roche Diagnostics
• Other prominent vendors
PART 19: Appendix
• List of abbreviation
PART 20: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: IDF estimate of diabetes population by region 2015
Exhibit 03: Cost breakdown of insulin pump therapy 2014
Exhibit 04: Cost breakdown of MDI 2014
Exhibit 05: Cost analysis of insulin pump consumables 2014
Exhibit 06: Cost analysis of MDI consumables for fast acting vial 2014
Exhibit 07: Cost analysis of MDI consumables for basal/long-acting insulin 2014
Exhibit 08: Cost comparison of MDI 2014
Exhibit 09: Average cost of cartridges offered by some of leading vendors 2014
Exhibit 10: Global insulin pumps market 2015-2020 ($ billions)
Exhibit 11: Five forces analysis
Exhibit 12: Insulin pumps market in the US 2015-2020 ($ millions)
Exhibit 13: Global insulin pumps market by geography 2015
Exhibit 14: Insulin pumps market in Americas 2015-2020 ($ millions)
Exhibit 15: Insulin pumps market in EMEA 2015-2020 ($ millions)
Exhibit 16: Insulin pumps market in APAC 2015-2020 ($ millions)
Exhibit 17: Global insulin pumps market by geography 2015-2020 ($ millions)
Exhibit 18: Global insulin pumps market by geography 2015-2020
Exhibit 19: Estimated percentage of older adult population 2012 and 2050
Exhibit 20: Impact of drivers
Exhibit 21: Impact of drivers and challenges
Exhibit 22: Vendor ranking of global insulin pumps market 2015
Exhibit 23: Global insulin pumps market share analysis 2015
Exhibit 24: Product matrix
Exhibit 25: Animas: Key takeaways
Exhibit 26: Insulet: Key takeaways
Exhibit 27:
Exhibit 28: Diabetes group by revenue 2013-2015 ($ billions)
Exhibit 29: Medtronic: Key takeaways
Exhibit 30: Diabetic care 2013-2015 ($ billions)
Exhibit 31: Roche Diagnostics: Key takeaways
